高流量鼻氧与喉罩机械通气在无肌松全麻中的随机对照试验
单中心随机非劣效试验纳入180例ASA I-II级宫腔镜手术患者,比较无肌松全麻下高流量鼻氧(70 L/min,FiO2 100%)与喉罩机械通气的术中呼吸支持成功率。两组成功率均为99%(绝对差0,单侧95%CI 3%,非劣效P<.001),高流量组术后呼吸症状更少(2% vs 19%),但经皮二氧化碳更高,43%患者>55 mm Hg。
要点
- 高流量鼻氧在30分钟无肌松全麻中呼吸支持成功率非劣效于喉罩通气。
- 高流量组术后呼吸症状发生率显著低于喉罩组(2% vs 19%)。
- 高流量组43%患者术中经皮二氧化碳>55 mm Hg,需谨慎选患者并监测。
核心结论
- 在30分钟无肌松全麻中,高流量鼻氧的术中呼吸支持成功率非劣效于喉罩机械通气。
- 高流量鼻氧组术后呼吸症状更少,但高碳酸血症风险需关注。
研究设计与样本
- 单中心、随机、非劣效试验,意大利2022年5月至2023年6月开展。
- 纳入ASA I-II级择期宫腔镜手术全麻患者180例,每组90例。
- 丙泊酚靶控输注全麻,不使用神经肌肉阻滞。
主要发现
- 两组术中呼吸支持成功率均为99%(89/90),绝对差0,单侧95%CI 3%,非劣效P<.001。
- 术后呼吸症状发生率:高流量组2%,喉罩组19%,P<.001。
- 气道相关并发症和术后呼吸困难两组无差异。
- 高流量组术中经皮二氧化碳显著更高,43%患者>55 mm Hg。
关键数值与推荐
- 主要结局呼吸支持成功定义:SpO2>94%且经皮二氧化碳<65 mm Hg,全程无需补救气道干预。
- 喉罩组目标:呼气末二氧化碳35-45 mm Hg,SpO2>95%。
- 高流量鼻氧参数:70 L/min,FiO2 100%。
- 中位麻醉时长:高流量组25(20-36)分钟,喉罩组32(27-44)分钟。
临床怎么用
- 高流量鼻氧可作为短时无肌松全麻的呼吸支持选择,但需选择合适患者。
- 使用高流量鼻氧时应加强经皮二氧化碳监测,警惕高碳酸血症。
局限性
- 单中心研究,样本量180例,外推需谨慎。
- 仅纳入ASA I-II级宫腔镜手术患者,麻醉时长约30分钟。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Apneic oxygenation with high-flow nasal oxygen is a novel intraoperative respiratory support strategy for patients undergoing general anesthesia, but data about its clinical effects are scarce. We conducted a randomized trial to assess whether high-flow nasal oxygen is noninferior to mechanical ventilation through a laryngeal mask in terms of success rate of intraoperative respiratory support among patients undergoing a 30-minute general anesthesia session. METHODS: Single-center, randomized, noninferiority trial conducted in Italy between May 2022 and June 2023 and involving American Society of Anesthesiologists class I and II patients undergoing general anesthesia for operative hysteroscopy. Participants were randomized to receive laryngeal mask ventilation (volume-controlled ventilation to obtain end-tidal carbon dioxide between 35 and 45 mm Hg, inhaled oxygen fraction to achieve peripheral oxygen saturation greater than 95%) or high-flow nasal oxygen (70 L per minute, inhaled oxygen fraction of 100%) for intraoperative respiratory support. Patients received general anesthesia with propofol target-controlled infusion without neuromuscular blockade. Primary outcome was intraoperative respiratory support success rate, which was defined as peripheral oxygen saturation greater than 94% and transcutaneous carbon dioxide lower than 65 mm Hg with no need for rescue airway interventions for the entire procedure. Secondary outcomes included the rate of airway-related complications (including need for bag-mask or laryngeal mask ventilation, or tracheal intubation), postoperative respiratory symptoms, and postoperative dyspnea. RESULTS: All 180 patients who were randomized completed the trial (90 patients in each group). Median [interquartile range] anesthesia duration was 25 [20-36] minutes in high-flow group and 32 minutes [27-44] in the laryngeal mask group. Intraoperative respiratory support was successful in 89 patients (99%) in both groups (absolute difference 0, unilateral 95% confidence interval, 3%, noninferiority P < .001). Incidence of postoperative respiratory symptoms was significantly lower in high-flow versus laryngeal mask group (2% vs 19%, P < .001), while airway-related complications and postoperative dyspnea were not different. Intraoperative transcutaneous carbon dioxide was significantly higher in high-flow group, with 43% of patients showing values greater than 55 mm Hg. CONCLUSIONS: High-flow nasal oxygen is noninferior to laryngeal mask ventilation for intraoperative respiratory support during 30-minute general anesthesia without muscle paralysis. The risk of hypercarbia warrants careful patient selection and monitoring.
引用
- Frassanito L, Grieco DL, Vassalli F, et al. High-Flow Nasal Oxygen versus Mechanical Ventilation Through a Laryngeal Mask During General Anesthesia Without Muscle Paralysis: A Randomized Clinical Trial. Anesth Analg. 2025. PMID: 40690380. doi:10.1213/ANE.0000000000007620
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。